Nelson Chao, MD, PhD, MBA Professor of Medicine, Chief, Division of Cell Therapy; Duke University Medical Center (Peripheral Blood)

EJ Shpall, M.D. Chair, Stem Cell TransplantaOon, MD Anderson Cancer Center (Cord Blood Collaboration)

Richard Childs, M.D. Chief – Cancer Immunotherapy, NaOonal Heart Lung and Blood Institute (NK cell collaboration)Clinical Director, National Heart Lung and Blood Institute, NIH, Bethesda, MD

Charles F. LeMaistre, M.D.
President, Texas Transplant Institute

Carl Pepine, M.D. 
Lead Cardiologist, Professor, University of Florida

Maria Grant, M.D. 
Diabetic Retinopathy, Professor, University of Florida

Michael Murphy, M.D.
Vascular Surgeon, Associate Professor, University of Indiana School of Medicine

Brian H. Johnstone, Ph.D.
Critical Limb Ischemia, Associate Professor, University of Indiana School of Medicine

Rodger McEver, M.D. 
Program Chair, Professor, Cardiovascular Biology Research Program, Oklahoma Medical Research Foundation (Co-inventor of TZ101 technology)

Lawrence Sherman, Ph.D. 
Professor at Oregon Health & Science University

Shay Soker, Ph.D. 
Professor at Wake Forest & Director at Armed Forces Institute of Regenerative Medicine

Lijun Xia, M.D., Ph.D. 
Associate Member, Cardiovascular Biology Research Program, Oklahoma Medical Research Foundation (Co-inventor of TZ101 technology)

Carlos Bachier, M.D. 
Research Director, Texas Transplant Institute

Pablo Rubenstein, MD –Medical Director, New York Blood Center; Founder, National Cord Blood Program (Cord Blood)

John DiPersion, MD, Ph.D. –Chief, Bone Marrow TransplantaOon/Stem Cell Biology, Washington University School of Medicine (CAR-T)

Todd Fehninger, MD, PhD – Professor of Medicine, Division of Oncology, Washington University School of Medicine (NK Cell Collaborator

Jeffrey Bluestone, PhD – President and CEO of the Parker Insitute for Cancer Immunotherapy; Chief, Diabetes Program, University of California, San Francisco (T-Regs, Type 1 Diabetes)

Beth Mittendorf, MD, PhD – MD Anderson Cancer Center – MDACC PI for Breast Cancer Study; Dana Farber (T-Cell therapy)

Gheath Alatrash, MD, PhD – MD Anderson Cancer Center – MDACC PI for CAR-T Cell & Cytoxic T-Cell Therapy Projects (T-Cell Therapy)

Joseph Levanthal MD, PhD– Northwestern University Medical Center, Solid Organ TransplantaOon (R-Regs, Solid Organ Transplant)

Marcela Maus, MD, PhD – Harvard Medical Center, Mass General Hospital (EGFR CAR-T Cell Therapy)

James Mason MD – Chief of Scripps/MD Anderson Cancer Center Division of Hematology/ Oncology

Marcos Di Lima MD, Chief, of Cleveland Clinic Division Of Hematology/Oncology

Run Wang, MD – Chief, Urology, University of Texas Houston Health Science Center. (MSCs, Erectile Dysfunction/Prostate Cancer Collaborator)

Edmund Moon, MD – Assistant Professor of Medicine, Pulmonology. University of Pennsylvania Medical Center (CAR-T, TCR)